China Tongfu: CNNC plans to transfer all of its approximately 106.7 million shares of domestic capital stock to China Baoyuan Investment for free.

China Tongfu announced that it has received a notification from its controlling shareholder, China National Nuclear Corporation (CNNC), regarding the transfer of its entire holding of approximately 106.7 million shares of the company's domestic stock (representing approximately 33.35% of the total issued share capital as of the date of this announcement) to China Baoyuan Investment Co., Ltd. (the transferee) as part of an internal restructuring within the CNNC group. The transferee and the company are both controlled by CNNC and are its direct and indirect subsidiaries, respectively. The transferee is a wholly-owned subsidiary of CNNC, a limited company established in China, dedicated to implementing CNNC's long-term strategic development in the application of nuclear technology. Its business covers most areas of nuclear technology application, forming an industrial chain from technology, products to service applications. By integrating research and development, production, sales, and services, the transferee has consolidated its leading position in the nuclear technology industry and medical applications. Since the company's listing on the Main Board of the Hong Kong Stock Exchange in 2018, the transferee has been a shareholder of the company, holding approximately 0.44% of the issued share capital (domestic shares) as of the date of this announcement. Upon completion of the proposed transfer, the transferee will become the direct controlling shareholder of the company, while CNNC will remain the ultimate controlling shareholder.